首页> 外文期刊>中德临床肿瘤学杂志(英文版) >草酸铂联合氟尿嘧啶、醛氢叶酸治疗晚期结直肠癌的临床观察
【24h】

草酸铂联合氟尿嘧啶、醛氢叶酸治疗晚期结直肠癌的临床观察

机译:草酸铂联合氟尿嘧啶、醛氢叶酸治疗晚期结直肠癌的临床观察

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To observe the efficacy and tolerability of continuously infusing 5-fluorouracii(5-FU)/folic acid combined with oxaliplatin(L-OHP/5-FU/Lv regimen)as first line treatment in advanced colorectal cancer.Methods:23 patients of advanced colorectal cancer were treated with 5-Fu 500mg/d,civ,d1-d5,d8-d12,leucovorin 100mg/d,iv gtt,d1,d8,folic acid tablet 60 mg/d,po,d2-d5,d9-d12,and oxaliplatin 65mg/(m2-d),iv gtt,d1,d8,repeated every 21 days(one cycle).The effect was evaluated after two cycles.Results:Complete response in 2 cases and partial response in 10 cases were observed with an overall response rate of 47.18%.Adverse effects were mainly grade 1-2,including nausea,vomiting,diarrhea,dental ulcer,peripheral neuritis and myelosuppression.Conclusion:L-OHP/5-FU/LV regimen is an effective and better tolerated alterna tive treatment in advanced colorectal cancer and yields promising clinical application.
机译:目的:观察连续输注5-氟脲(5-FU)/叶酸联合奥沙利铂(L-OHP / 5-FU / LV方案)作为晚期结直肠癌的第一线治疗的疗效和耐受性。方法:23例患者用5-FU 500mg / d,CIV,D1-D5,D8-D12,Leucovorin 100mg / D,IV GTT,D1,D8,叶酸片60mg / D,D2-D5处理晚期结直肠癌。 D9-D12和Oxaliplatin 65mg /(M2-D),IV GTT,D1,D8,每21天重复(一个循环)。在两个循环后评估效果。结果:在2例中进行完全反应和10通过整体反应率观察到47.18%的案件。论主要是1-2级,包括恶心,呕吐,腹泻,牙科溃疡,外周神经炎和髓鞘抑制。结论:L-OHP / 5-FU / LV方案是一个晚期结直肠癌的有效和更好的耐受性的替代治疗,并产生了有前途的临床应用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号